The lncRNA CASC2 Modulates Hepatocellular Carcinoma Cell Sensitivity and Resistance to TRAIL Through Apoptotic and Non-Apoptotic Signaling

The immune cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been widely concerned as a tumor therapy because of its ability of selective triggering cancer cell apoptosis; nevertheless, hepatocellular carcinoma (HCC) exhibits acquired resistance to TRAIL-induced apoptosis....

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jichun, Xu, Hongbo, Lei, Zhao, Li, Zhiqiang, Zhu, Hongwei, Deng, Zhen, Yu, Xiao, Jin, Xiaoxin, Yang, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823509/
https://www.ncbi.nlm.nih.gov/pubmed/35145900
http://dx.doi.org/10.3389/fonc.2021.726622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823509/
https://www.ncbi.nlm.nih.gov/pubmed/35145900
http://dx.doi.org/10.3389/fonc.2021.726622

Ejemplares similares